ClinicalTrials.govpublic full text
Phase II Trial of XP Versus XG in Advanced Esophageal Squamous Cell Carcinoma
advanced or recurrent esophageal squamous cell carcinoma, randomizes phase ii trial, capecitabine, cisplatin, genexol, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884109
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.